|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3116909 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15713290.3 |
| Date of filing the European patent application | 2015-03-13 | |
| (97) | Date of publication of the European application | 2017-01-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-13 |
| (46) | Date of publication of the claims translation | 2020-02-10 |
| (86) | Number | PCT/US2015/020474 |
| Date | 2015-03-13 |
| (87) | Number | WO 2015/138920 |
| Date | 2015-09-17 |
| (30) | Number | Date | Country code |
| 201461953536 P | 2014-03-14 | US | |
| 201462059690 P | 2014-10-03 | US | |
| 201462094889 P | 2014-12-19 | US |
| (72) |
TRIEBEL, Frederic, FR
BRIGNONE, Chrystelle, FR
BLATTLER, Walter A., US
MATARAZA, Jennifer Marie, US
SABATOS-PEYTON, Catherine Anne, US
CHANG, Hwai Wen, US
FREY, Gerhard Johann, US
|
| (73) |
NOVARTIS AG,
Lichtstrasse 35, 4056 Basel,
CH
Immutep S.A.S., Parc Club Orsay 2 Rue Jean Rostand, 91893 Orsay, FR |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Antikūno molekulės prieš LAG-3 ir jų panaudojimas |
| ANTIBODY MOLECULES TO LAG-3 AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-02-23 | 12 | 289.00 EUR |
| 2027-03-13 |